Company / Cash per Share
Dianthus Therapeutics, Inc. /DE/ Cash per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$1.64
FY2025
5-year range
$1.54 / $25.68
FY2021-FY2025
Trend
+6.7%
vs FY2024
Sector context
#118 of 205
Health Care
What the data says
At $1.64, Dianthus Therapeutics, Inc. /DE/'s cash per share ranks #118 of 205 in the Health Care sector. Cash per Share has fluctuated over the past 9 years, ranging from $1.32 in FY2020 to $27.68 in FY2017.
Based on SEC 10-K filings.
1.64 in FY2025 with a 5-year CAGR of +4.4%.
Declined from $25.68 to $1.64 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -54.6%
- 5-Year CAGR
- +4.4%
- 10-Year CAGR
- -
Sector benchmark
#118 of 205 in Health CareTop 58% of 205This company $1.64 Sector average $67.98
▼
-97.6% below sector average
Key checks
Key Insights
- In FY2025, cash per share increased 6.7% year-over-year.
- Ranks #118 out of 205 companies in the Health Care sector.
- Peak cash per share was recorded in FY2017.
- Lowest cash per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 4.46 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.64 | +6.7% |
| FY2024 | $1.54 | -94.0% |
| FY2023 | $25.68 | +46.1% |
| FY2022 | $17.58 | +633.6% |
| FY2021 | $2.40 | +81.0% |
| FY2020 | $1.32 | -32.2% |
| FY2019 | $1.95 | -92.1% |
| FY2018 | $24.81 | -10.4% |
| FY2017 | $27.68 | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026